Relationship between skin involvement and disease burden in patients with mild to moderate plaque psoriasis: Real-world findings From CorEvitas' Psoriasis Registry

被引：0
|
作者：
Ogdie, Alexis [1 ]
Strober, Bruce [2 ]
Lebwohl, Mark [3 ]
机构：
[1] Univ Pennsylvania, Philadelphia, PA USA
[2] Yale Univ, New Haven, CT USA
[3] Icahn Sch Med Mt Sinai, New York, NY USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
33933
引用
收藏
页码：AB103 / AB103
页数：1
相关论文
共 50 条
  • [41] Safety of tildrakizumab in a Phase 4 real-world study in patients with moderate-to-severe plaque psoriasis
    Vasquez, J. Gabriel
    Bhatia, Neal
    Schenkel, Brad
    Rozzo, Stephen J.
    Heim, Jayme
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB85 - AB85
  • [42] Real-world experience on the efficacy and safety of apremilast in bio-naive patients with moderate plaque psoriasis
    Conti, Andrea
    Tiberio, Rossana
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) : 1900 - 1900
  • [43] Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence
    Tina Bhutani
    Aaron S. Farberg
    [J]. Dermatology and Therapy, 2024, 14 : 341 - 360
  • [44] Clinical and Disease Burden of Patients with Generalized Pustular Psoriasis: A Review of Real-World Evidence
    Bhutani, Tina
    Farberg, Aaron S.
    [J]. DERMATOLOGY AND THERAPY, 2024, 14 (02) : 341 - 360
  • [45] REAL-WORLD DATA ON THE EFFICACY AND SAFETY OF IXEKIZUMAB IN PATIENTS WITH PLAQUE PSORIASIS
    Stefanaki, Irene
    Rompoti, Natalia
    Panagakis, Pantelis
    Papoutsaki, Marina
    Politou, Maria
    Vavouli, Charitomeni
    Mpefon, Aggeliki
    Fiori, Kousta
    Eleni, Lazou
    Zaimi, Maria
    Koumprentziotis, Ioannis-Alexios
    Zafeiropoulou, Theodora
    Chasapi, Vasiliki
    Stratigos, Alexander
    Nicolaidou, Electra
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [46] Real-world experience with risankizumab in patients with plaque psoriasis: a retrospective study
    Mehta, M.
    O'Toole, A.
    Gooderham, M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (10) : E685 - E688
  • [47] Blood microRNA expressions in patients with mild to moderate psoriasis and the relationship between microRNAs and psoriasis activity
    Alatas, Emine Tugba
    Kara, Murat
    Dogan, Gursoy
    Belli, Asli Akin
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2020, 95 (06) : 702 - 707
  • [48] Real-world health outcomes in US adult patients with mild-to-moderate plaque psoriasis taking topical therapy: Results from a chart review
    Nazareth, Tara
    Hetherington, James
    Lucas, James
    Khilfeh, Ibrahim
    Nunez-Gomez, Natalie
    Kaplan, David
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB21 - AB21
  • [49] Burden of flares on patients with moderate to severe psoriasis: results of the Adelphi Real World Psoriasis Disease Specific Programme in the United States
    Hsu, Ming-Ann
    Lucas, James
    Wood, Robert
    Cappelleri, Joseph C.
    Piercy, James
    Mallbris, Lotus
    Mamolo, Carla
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S34 - S34
  • [50] Real-world evidence of Guselkumab for the treatment of moderate-to-severe psoriasis: Efficacy and drug survival analysis from the Australasian Psoriasis Registry
    Manuelpillai, Nicholas
    Parikh, Sumit
    Puig, Andrea
    Maranta, Debra
    Foley, Peter
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 9 - 9
12345